This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H7N9 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His
Product Overview
BioVenic's Recombinant Influenza A H7N9 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 31.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The H7N9 M2e is the highly conserved 23-amino acid extracellular domain of the M2 ion channel from the avian-origin H7N9 influenza virus. While the H7N9 hemagglutinin evolves rapidly to evade immune detection, M2e serves as a stable antigenic target. It is expressed at high density on the surface of infected lung epithelial cells. Research focuses on H7N9 M2e for developing universal vaccines and therapeutic antibodies that provide broad-spectrum protection against this high-mortality subtype through Fc-mediated immune recruitment.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.